MATINAS BIOPHARMA HOLDINGS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 16.28 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 16.34B shares, a 70.23% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 9.60B shares, a 1042365.66% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 920.63K shares, a 97.36% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 34.92M shares, a 21.51% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 16.36M shares, a 1108.08% increase from fiscal 2024.
- MATINAS BIOPHARMA HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.35M shares, a 44.95% increase from fiscal 2023.
- MATINAS BIOPHARMA HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 934.16K shares, a 97.33% decline from fiscal 2022.
- MATINAS BIOPHARMA HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 34.98M shares, a 19.90% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 16.28M shares 10-Q · filed 2026-08-13 | |||||||
| 2026-03-31 | 16.34B shares 10-Q · filed 2026-05-08 | |||||||
| 2025-12-31 | 16.36M shares 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | 17.20M shares 10-Q · filed 2025-11-10 | |||||||
| 2025-06-30 | 18.03M shares 10-Q · filed 2026-08-13 | |||||||
| 2025-03-31 | 9.60B shares 10-Q · filed 2026-05-08 | 9.60M shares 10-Q · filed 2025-05-15 | ||||||
| 2024-12-31 | 1.35M shares 10-K · filed 2026-03-31 | |||||||
| 2024-09-30 | 1.54M shares 10-Q · filed 2025-11-10 | |||||||
| 2024-06-30 | 1.59M shares 10-Q · filed 2025-08-14 | 79.36M shares 10-Q · filed 2024-08-14 | ||||||
| 2024-03-31 | 920.63K shares 10-Q · filed 2025-05-15 | 46.03M shares 10-Q · filed 2024-05-09 | ||||||
| 2023-12-31 | 934.16K shares 10-K · filed 2025-04-15 | 46.71M shares 10-K · filed 2024-03-27 | ||||||
| 2023-09-30 | 664.69K shares 10-Q · filed 2024-11-13 | 33.23M shares 10-Q · filed 2023-11-08 | ||||||
| 2023-06-30 | 34.54M shares 10-Q · filed 2024-08-14 | 34.54M shares 10-Q · filed 2023-08-09 | ||||||
| 2023-03-31 | 34.92M shares 10-Q · filed 2024-05-09 | 34.92M shares 10-Q · filed 2023-05-10 | ||||||
| 2022-12-31 | 34.98M shares 10-K · filed 2024-03-27 | |||||||
| 2022-09-30 | 28.72M shares 10-Q · filed 2023-11-08 | 28.77M shares 10-Q · filed 2022-11-02 | ||||||
| 2022-06-30 | 28.72M shares 10-Q · filed 2023-08-09 | |||||||
| 2022-03-31 | 28.74M shares 10-Q · filed 2023-05-10 | |||||||
| 2021-12-31 | 29.17M shares 10-K · filed 2023-03-15 | |||||||
| 2021-09-30 | 23.23M shares 10-Q · filed 2022-11-02 | |||||||
| 2021-06-30 | 23.49M shares 10-Q · filed 2022-08-11 | |||||||
| 2021-03-31 | 34.34M shares 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | 32.60M shares 10-K/A · filed 2022-03-11 | 32.60K shares 10-K · filed 2021-03-29 | ||||||
| 2020-09-30 | 32.69M shares 10-Q · filed 2021-11-08 | 32.69K shares 10-Q · filed 2020-11-06 | ||||||
| 2020-06-30 | 32.75M shares 10-Q · filed 2021-08-10 | 32.75K shares 10-Q · filed 2020-08-10 | ||||||
| 2020-03-31 | 33.04M shares 10-Q · filed 2021-05-10 | 33.04K shares 10-Q · filed 2020-05-11 | ||||||
| 2019-12-31 | 32.08K shares 10-K · filed 2021-03-29 | 32.08M shares 10-K · filed 2020-03-09 | ||||||
| 2019-09-30 | 31.90K shares 10-Q · filed 2020-11-06 | 31.90M shares 10-Q · filed 2019-11-13 | ||||||
| 2019-06-30 | 48.71K shares 10-Q · filed 2020-08-10 | 48.71M shares 10-Q · filed 2019-08-13 | ||||||
| 2019-03-31 | 48.86K shares 10-Q · filed 2020-05-11 | 48.86M shares 10-Q · filed 2019-05-13 | ||||||
| 2018-12-31 | 45.92M shares 10-K · filed 2020-03-09 | |||||||
| 2018-09-30 | 45.94M shares 10-Q · filed 2018-11-09 | 45.94M shares 10-Q · filed 2019-11-13 | ||||||
| 2018-06-30 | 48.96M shares 10-Q · filed 2018-08-09 | 48.96M shares 10-Q · filed 2019-08-13 | ||||||
| 2018-03-31 | 32.30M shares 10-Q · filed 2019-05-13 | |||||||
| 2017-12-31 | 33.56M shares 10-K · filed 2019-04-01 | 32.38M shares 10-K · filed 2018-03-16 | ||||||
| 2017-09-30 | 32.56M shares 10-Q · filed 2018-11-09 | 32.56M shares 10-Q · filed 2018-11-09 | ||||||
| 2017-06-30 | 32.23M shares 10-Q · filed 2018-08-09 | 32.23M shares 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | 32.60M shares 10-Q · filed 2018-05-09 | 32.60K shares 10-Q · filed 2017-05-15 | ||||||
| 2016-12-31 | 64.55M shares 10-K · filed 2018-03-16 | 64.55K shares 10-K · filed 2017-03-31 | ||||||
| 2016-09-30 | 64.84M shares 10-Q · filed 2017-11-14 | 64.84M shares 10-Q · filed 2017-11-14 | 64.84M shares 10-Q · filed 2016-11-14 | |||||
| 2016-06-30 | 47.52M shares 10-Q · filed 2017-08-08 | 47.52M shares 10-Q · filed 2017-08-08 | 47.52M shares 10-Q · filed 2016-08-15 | |||||
| 2016-03-31 | 47.53K shares 10-Q · filed 2017-05-15 | 47.53M shares 10-Q · filed 2016-05-13 | ||||||
| 2015-12-31 | 45.34M shares 10-K · filed 2018-03-16 | |||||||
| 2015-09-30 | 46.33M shares 10-Q · filed 2016-11-14 | |||||||
| 2015-06-30 | 46.01M shares 10-Q · filed 2016-08-15 | |||||||
| 2015-03-31 | 33.94M shares 10-Q · filed 2016-05-13 | |||||||
| 2014-12-31 | 20.60M shares 10-K · filed 2016-03-30 | |||||||
| 2014-09-30 | 20.66M shares 10-Q · filed 2015-11-10 | |||||||
| 2014-06-30 | 18.31M shares 10-Q · filed 2015-08-13 | |||||||
| 2014-03-31 | 18.41M shares 10-Q · filed 2015-05-15 | |||||||
| 2013-12-31 | 18.41M shares 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |